/Companies

RosVivo Therapeutics

Reno, US · Founded 2021 · Nevada corporation

Find your way into RosVivo Therapeutics

Sign up to see every warm intro you have to RosVivo Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the RosVivo Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

SR
Seungil RoNamed on SEC filing
SM
Sandra M. PoudrierNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$5.5M disclosed across 1 round · 2021

▶$5.5MraisedJun 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Seungil RoExecutive Officer
  • Sandra M. PoudrierExecutive Officer
Offering amount
$5.5M
Amount sold
$5.5M
Minimum investment
$5.5M
Finders' fees
$163.6K
First sale
May 2021
Incorporated
Corporation, Nevada, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has RosVivo Therapeutics raised?
RosVivo Therapeutics has disclosed $5.5M raised across 1 round.
Where is RosVivo Therapeutics headquartered?
RosVivo Therapeutics is headquartered in Reno, US.